(Q51372794)

4 April 2018

title

Effect of different immunosuppressive regimens on the evolution of distinct metabolic parameters: evidence from the Symphony study. (English)

1 reference

4 April 2018

author

Philip F Halloran

5

1 reference

4 April 2018

author name string

Kathleen Claes

1

1 reference

4 April 2018

Herwig-Ulf Meier-Kriesche

2

1 reference

4 April 2018

Jesse D Schold

3

1 reference

4 April 2018

Yves Vanrenterghem

4

1 reference

4 April 2018

Henrik Ekberg

6

1 reference

4 April 2018

language of work or name

English

0 references

publication date

26 May 2011

1 reference

4 April 2018

Nephrology Dialysis Transplantation

published in

1 reference

4 April 2018

volume

27

1 reference

4 April 2018

issue

2

1 reference

4 April 2018

page(s)

850-857

1 reference

4 April 2018

Impact of metabolic syndrome on graft function and survival after cadaveric renal transplantation

cites work

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

Metabolic syndrome is associated with impaired long-term renal allograft function; not all component criteria contribute equally.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

Reduced exposure to calcineurin inhibitors in renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

Definition of metabolic syndrome: Report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

Efficacy and safety of tacrolimus compared with ciclosporin microemulsion in renal transplantation: a randomised multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

One-year follow-up of a Brazilian randomized multicenter study comparing tacrolimus versus cyclosporine in kidney transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

Different effects of tacrolimus and cyclosporine on renal hemodynamics and blood pressure in healthy subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

Multicenter randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of renal allograft rejection: a report of the European Tacrolimus Multicenter Renal Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

A comparison of tacrolimus (FK506) and cyclosporine for immunosuppression after cadaveric renal transplantation. FK506 Kidney Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

Efficacy and safety of tacrolimus compared with cyclosporin microemulsion in primary SPK transplantation: 3-year results of the Euro-SPK 001 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

Conversion from cyclosporine to tacrolimus improves quality-of-life indices, renal graft function and cardiovascular risk profile

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

Complete avoidance of calcineurin inhibitors in renal transplantation: a randomized trial comparing sirolimus and tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

Diabetes mellitus after kidney transplantation in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

Glucose metabolism in renal transplant recipients: effect of calcineurin inhibitor withdrawal and conversion to sirolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

Sirolimus is associated with new-onset diabetes in kidney transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

Sirolimus (rapamycin)-based therapy in human renal transplantation: similar efficacy and different toxicity compared with cyclosporine. Sirolimus European Renal Transplant Study Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

Metabolic and hormonal effects of tacrolimus (FK506) or cyclosporin immunosuppression following renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

Relative risk of new-onset diabetes during the first year after renal transplantation in patients receiving tacrolimus or cyclosporine immunosuppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

Results of an international, randomized trial comparing glucose metabolism disorders and outcome with cyclosporine versus tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

Tacrolimus reversibly reduces insulin secretion in paediatric renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

Posttransplantation diabetes: a systematic review of the literature

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

Comparative risk of impaired glucose metabolism associated with cyclosporine versus tacrolimus in the late posttransplant period

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

Bicêtre hospital experience with sirolimus-based therapy in human renal transplantation: the sirolimus European renal transplant study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

Sirolimus does not exhibit nephrotoxicity compared to cyclosporine in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen: incidence, risk factors, progression, and prognosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

Randomized trial of tacrolimus in combination with sirolimus or mycophenolate mofetil in kidney transplantation: results at 6 months1

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

Comparison of rival metabolic syndrome classifications against pathophysiological markers in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

Steroid avoidance or withdrawal after renal transplantation increases the risk of acute rejection but decreases cardiovascular risk. A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

Weight changes after renal transplantation: a comparison between patients on 5-mg maintenance steroid therapy and those on steroid-free immunosuppressive therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FNDT%2FGFR238

21 January 2018

Identifiers

DOI

10.1093/NDT/GFR238

1 reference

4 April 2018

PubMed ID

21617197

1 reference

4 April 2018